Randomized phase II trial of vincristine-irinotecan with or without temozolomide, in children and adults with relapsed or refractory rhabdomyosarcoma: a European paediatric soft tissue sarcoma study group and innovative therapies for children with cancer trial

Anne-Sophie Defachelles, Emilie Bogart, Michela Casanova, Johannes H M Merks, Gianni Bisogno, Giuseppina Calareso, Soledad Gallego Melcon, Susanne Andrea Gatz, Marie-Cécile Le Deley, Kieran McHugh, Alicia Probst, Nathalie Rocourt, Rick R van Rijn, Keith Wheatley, Véronique Minard-Colin, Julia C Chisholm

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Randomized phase II trial of vincristine-irinotecan with or without temozolomide, in children and adults with relapsed or refractory rhabdomyosarcoma: a European paediatric soft tissue sarcoma study group and innovative therapies for children with cancer trial'. Together they form a unique fingerprint.

Medicine & Life Sciences